Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kisseberth

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
BMC Cancer|January 23, 2017
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosisSridhar Murahari, Aimee L Jalkanen, Samuel K Kulp, et al.
BMC Cancer|February 13, 2014
Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasisJoelle M Fenger, Misty D Bear, Stefano Volinia, et al.
Experimental Hematology|June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphomaD M Vail, W C Kisseberth, J E Obradovich, et al.
Veterinary and Comparative Oncology|September 17, 2009
Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasiaD M W Schaefer, M A Forman, W C Kisseberth, et al.
Journal of Veterinary Internal Medicine|January 17, 2008
Comparison of COAP and UW-19 protocols for dogs with multicentric lymphomaKenji Hosoya, William C Kisseberth, Linda K Lord, et al.
Frontiers in Veterinary Science|September 10, 2021
Case Report: Metastatic Parosteal Osteosarcoma in a DogSarah K Samuels, Matthew R Cook, Eric Green, et al.
BMC Veterinary Research|July 16, 2014
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell linesMegan N Breit, William C Kisseberth, Misty D Bear, et al.
Veterinary Dermatology|July 9, 2021
Treatment of indolent cutaneous T-cell lymphoma with hypofractionated radiation therapy in three catsLaura E Chadsey, Matthew R Cook, Eric E Green, et al.
Frontiers in Veterinary Science|November 8, 2021
Case Report: Cutaneous Pleomorphic Lymphangiosarcoma in a Dog Exhibiting Features of Human Composite HemangioendotheliomaMatthew R Cook, Joshua N Lorbach, Mary E White, et al.
BMC Cancer|March 17, 2009
Characterization of STAT3 activation and expression in canine and human osteosarcomaStacey L Fossey, Albert T Liao, Jennifer K McCleese, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
BMC Cancer|January 23, 2017
Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosisSridhar Murahari, Aimee L Jalkanen, Samuel K Kulp, et al.
BMC Cancer|February 13, 2014
Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasisJoelle M Fenger, Misty D Bear, Stefano Volinia, et al.
Experimental Hematology|June 1, 1996
Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphomaD M Vail, W C Kisseberth, J E Obradovich, et al.
Veterinary and Comparative Oncology|September 17, 2009
Quantification of plasma DNA as a prognostic indicator in canine lymphoid neoplasiaD M W Schaefer, M A Forman, W C Kisseberth, et al.
Journal of Veterinary Internal Medicine|January 17, 2008
Comparison of COAP and UW-19 protocols for dogs with multicentric lymphomaKenji Hosoya, William C Kisseberth, Linda K Lord, et al.
Frontiers in Veterinary Science|September 10, 2021
Case Report: Metastatic Parosteal Osteosarcoma in a DogSarah K Samuels, Matthew R Cook, Eric Green, et al.
BMC Veterinary Research|July 16, 2014
Biologic activity of the novel orally bioavailable selective inhibitor of nuclear export (SINE) KPT-335 against canine melanoma cell linesMegan N Breit, William C Kisseberth, Misty D Bear, et al.
Veterinary Dermatology|July 9, 2021
Treatment of indolent cutaneous T-cell lymphoma with hypofractionated radiation therapy in three catsLaura E Chadsey, Matthew R Cook, Eric E Green, et al.
Frontiers in Veterinary Science|November 8, 2021
Case Report: Cutaneous Pleomorphic Lymphangiosarcoma in a Dog Exhibiting Features of Human Composite HemangioendotheliomaMatthew R Cook, Joshua N Lorbach, Mary E White, et al.
BMC Cancer|March 17, 2009
Characterization of STAT3 activation and expression in canine and human osteosarcomaStacey L Fossey, Albert T Liao, Jennifer K McCleese, et al.
Pageof 9